For instance, BCR-ABL1-independent activation of STAT3 was found in TKI-resistant cell lines and primary CML cells from patients with clinical resistance to multiple TKIs [153], suggesting that STAT3 activation is a critical survival pathway in CML. Here, STAT3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.